Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Alp, Keziban Merve (1) Birchmeier, Walter Prof. Dr. (7) Blüthgen, Nils (1) Daniel, Peter Prof. Dr. (3) Fritsche, Raphaela Dr. (2) Haas, Simon Dr. rer. nat. (1) Hartl, Kimberly (1) Holz, Maximilian (1) Horne, Arik (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Janke, Jürgen Dr. (1) Janz, Martin Dr. (1) Keller, Ulrich Dr. med. (2) Kobelt, Dennis Dr. (51) Koch, Gudrun (1) Leutz, Achim Prof. Dr. (2) Malchin, Victoria (1) Mertins, Philipp Dr. (4) Na, Il-Kang Dr. (1) Nazare, Marc (1) Nguyen, Tam Hoai Dr. (1) Nimptsch, Katharina Dr. (1) Özerdem, Ceren (1) Pezzutto, Antonio Prof. Dr. (4) Pischon, Tobias Prof. Dr. (1) Popp, Oliver Dr. (3) Rathjen, Fritz Prof. Dr. (1) Rehm, Armin Dr. (1) Röefzaad, Claudia (1) Schlag, Peter M. Prof. Dr. (378) Schmitt, Clemens Prof. Dr. (2) Schöpe, Paul Curtis (2) Schroeder, Leif Dr. (1) Simon, Mareike Dr. (1) Smith, Janice (16) Solé Boldo, Llorenc Dr. rer. nat. (1) Specker, Edgar Dr. (2) Sperling, Silke Prof. Dr. (1) Sporbert, Anje Dr. (1) Stein, Ulrike Prof. Dr. (187) Torke, Sebastian Dr. (4) Uckert, Wolfgang Prof. Dr. (1) Veltsista, Paraskevi Danai (1) von Kries, Jens Peter Dr. (2) Walther, Wolfgang Prof. Dr. (145) Wenzel, Katrin Dr. (1) Willimsky, Gerald Dr. (1) Willnow, Thomas Prof. Dr. (1) Wolf, Jana Prof. Dr. (1) Zimmermann, Karin Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (2) (-) Dahlmann, Mathias Dr. (29) (-) Herse, Florian PD Dr. (1) Advanced Light Microscopy (3) AG Müller/Dechend (ECRC) (90) AG Schreiber [ECRC] (2) Angeborene Immunität & Neuroinflammation (2) Animal Phenotyping (9) Biobank (8) Clinical Research Unit (1) Electron Microscopy (1) Entwicklung Mechanismus-basierter Krebstherapien (1) Entwicklungsneurobiologie (1) Experimentelle Ultrahochfeld-MR (291) Flow Cytometry (1) Gastrointestinale Barriere, Regeneration und Karzinogenese (1) Genetik und Genomik von Herz- Kreislauferkrankungen (6) Genom-Editierung & Krankheitsmodelle (1) Genomics (1) Hochschulambulanz für Neuroimmunologie (29) Hypertonie-vermittelter Endorganschaden (90) Hypertonie bedingte Endorganschäden (90) Immundysregulationen in der Onkologie (2) Immunregulation und Krebs (1) Integrative Vaskuläre Biologie (1) Interdisziplinäre Retinaforschung (1) Kardiale MRT (33) Magnetic Resonance (291) Mikroumgebung als Regulator bei Autoimmunität und Krebs (1) Mobile DNA (2) Molekularbiologie von Hormonen im Herz-Kreislaufssystem (13) Molekulare Epidemiologie (8) Molekulare Herz- Kreislaufforschung (3) Molekulare Immunologie und Gentherapie (179) Molekulare Physiologie der somatosensorischen Wahrnehmung (1) Nephrologie und entzündliche Gefäßerkrankungen (2) Neuroimmunologie-Labor (1) Neuronale Schaltkreise und Verhalten (1) Nicht-Kodierende RNAs und Mechanismen der Genregulation im Cytoplasma (1) Pathogenese der ANCA-induzierten Glomerulonephritis (1) Protein Production and Characterization (1) Proteom Dynamik (2) Proteomics (5) Proteomics and Metabolomics (1) Psychoneuroimmunologie (3) Systembiologie von Gen-regulatorischen Elementen (1) Transgenics (1) Translational Bioinformatics (7) (-) Translationale Onkologie solider Tumore (32) Translationale Tumorimmunologie (1) Tumorgenetik und zelluläre Stressantworten (1) Zelluläre Neurowissenschaften (3) 1997 (1) 2007 (1) 2008 (1) 2010 (1) 2012 (1) 2014 (1) 2015 (2) 2016 (3) 2017 (2) 2018 (2) 2019 (2) 2020 (3) 2021 (5) 2022 (6) 2023 (1) 32 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Dahlmann, Mathias Dr.Herse, Florian PD Dr.Translationale Onkologie solider Tumore Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 30. Mai 2014 / Oncotarget RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis M. Dahlmann A. Okhrimenko P. Marcinkowski M. Osterland P. Herrmann J. Smith C.W. Heizmann P.M. Schlag U. Stein 04. Mai 2015 / Thyroid RAGE mediates the pro-migratory response of extracellular S100A4 in human thyroid cancer cells M.R. Medapati M. Dahlmann S. Ghavami K.A. Pathak L. Lucman T. Klonisch C. Hoang-Vu U. Stein S. Hombach-Klonisch 01. Januar 2015 / Methods Mol Biol RNA interference for antimetastatic therapy M. Dahlmann U. Stein 01. Januar 1997 / Hum Gene Ther Transient expression of SV 40 large T antigen by Cre/LoxP mediated site specific deletion in primary human tumor cells L.P. Li P.M. Schlag T. Blankenstein 01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein 01. Mai 2007 / Biol Chem Expression of the protein phosphatase 1 inhibitor KEPI is downregulated in breast cancer cell lines and tissues and involved in the regulation of the tumor suppressor EGR1 via the MEK-ERK pathway K. Wenzel K. Daskalow F. Herse S. Seitz U. Zacharias J.A. Schenk H. Schulz N. Huebner B. Micheel P.M. Schlag K.J. Osterziel C. Ozcelik S. Scherneck B. Jandrig 01. Januar 2010 / J Mol Med MACC1 - more than metastasis? Facts and predictions about a novel gene U. Stein M. Dahlmann W. Walther 07. August 2012 / Oncotarget Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation M. Dahlmann U. Sack P. Herrmann M. Lemm I. Fichtner P.M. Schlag U. Stein 01. April 2021 / Cell Mol Life Sci MACC1 regulates clathrin-mediated endocytosis and receptor recycling of transferrin receptor and EGFR in colorectal cancer F. Imbastari M. Dahlmann A. Sporbert C. Ciolli Mattioli T. Mari F. Scholz L. Timm S. Twamley R. Migotti W. Walther G. Dittmar A. Rehm U. Stein 26. August 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Seite 4 Nächste Seite Next › Letzte Seite Last »
30. Mai 2014 / Oncotarget RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis M. Dahlmann A. Okhrimenko P. Marcinkowski M. Osterland P. Herrmann J. Smith C.W. Heizmann P.M. Schlag U. Stein
04. Mai 2015 / Thyroid RAGE mediates the pro-migratory response of extracellular S100A4 in human thyroid cancer cells M.R. Medapati M. Dahlmann S. Ghavami K.A. Pathak L. Lucman T. Klonisch C. Hoang-Vu U. Stein S. Hombach-Klonisch
01. Januar 1997 / Hum Gene Ther Transient expression of SV 40 large T antigen by Cre/LoxP mediated site specific deletion in primary human tumor cells L.P. Li P.M. Schlag T. Blankenstein
01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein
01. Mai 2007 / Biol Chem Expression of the protein phosphatase 1 inhibitor KEPI is downregulated in breast cancer cell lines and tissues and involved in the regulation of the tumor suppressor EGR1 via the MEK-ERK pathway K. Wenzel K. Daskalow F. Herse S. Seitz U. Zacharias J.A. Schenk H. Schulz N. Huebner B. Micheel P.M. Schlag K.J. Osterziel C. Ozcelik S. Scherneck B. Jandrig
01. Januar 2010 / J Mol Med MACC1 - more than metastasis? Facts and predictions about a novel gene U. Stein M. Dahlmann W. Walther
07. August 2012 / Oncotarget Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation M. Dahlmann U. Sack P. Herrmann M. Lemm I. Fichtner P.M. Schlag U. Stein
01. April 2021 / Cell Mol Life Sci MACC1 regulates clathrin-mediated endocytosis and receptor recycling of transferrin receptor and EGFR in colorectal cancer F. Imbastari M. Dahlmann A. Sporbert C. Ciolli Mattioli T. Mari F. Scholz L. Timm S. Twamley R. Migotti W. Walther G. Dittmar A. Rehm U. Stein
26. August 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein